ELAN Long Put Strategy

ELAN (Elanco Animal Health Incorporated), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NYSE.

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

ELAN (Elanco Animal Health Incorporated) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $10.89B, a beta of 1.69 versus the broader market, a 52-week range of 12.4-27.72, average daily share volume of 5.5M, a public-listing history dating back to 2018, approximately 9K full-time employees. These structural characteristics shape how ELAN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.69 indicates ELAN has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a long put on ELAN?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current ELAN snapshot

As of May 15, 2026, spot at $19.97, ATM IV 47.90%, IV rank 35.84%, expected move 13.73%. The long put on ELAN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.

Why this long put structure on ELAN specifically: ELAN IV at 47.90% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 13.73% (roughly $2.74 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ELAN expiries trade a higher absolute premium for lower per-day decay. Position sizing on ELAN should anchor to the underlying notional of $19.97 per share and to the trader's directional view on ELAN stock.

ELAN long put setup

The ELAN long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ELAN near $19.97, the first option leg uses a $20.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ELAN chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ELAN shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Put$20.00$1.48

ELAN long put risk and reward

Net Premium / Debit
-$147.50
Max Profit (per contract)
$1,851.50
Max Loss (per contract)
-$147.50
Breakeven(s)
$18.53
Risk / Reward Ratio
12.553

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

ELAN long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on ELAN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price% From SpotP&L at Expiration
$0.01-99.9%+$1,851.50
$4.42-77.8%+$1,410.06
$8.84-55.7%+$968.63
$13.25-33.6%+$527.19
$17.67-11.5%+$85.75
$22.08+10.6%-$147.50
$26.50+32.7%-$147.50
$30.91+54.8%-$147.50
$35.32+76.9%-$147.50
$39.74+99.0%-$147.50

When traders use long put on ELAN

Long puts on ELAN hedge an existing long ELAN stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying ELAN exposure being hedged.

ELAN thesis for this long put

The market-implied 1-standard-deviation range for ELAN extends from approximately $17.23 on the downside to $22.71 on the upside. A ELAN long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long ELAN position with one put per 100 shares held. Current ELAN IV rank near 35.84% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on ELAN should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ELAN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ELAN-specific events.

ELAN long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ELAN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ELAN alongside the broader basket even when ELAN-specific fundamentals are unchanged. Long-premium structures like a long put on ELAN are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ELAN chain quotes before placing a trade.

Frequently asked questions

What is a long put on ELAN?
A long put on ELAN is the long put strategy applied to ELAN (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With ELAN stock trading near $19.97, the strikes shown on this page are snapped to the nearest listed ELAN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are ELAN long put max profit and max loss calculated?
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the ELAN long put priced from the end-of-day chain at a 30-day expiry (ATM IV 47.90%), the computed maximum profit is $1,851.50 per contract and the computed maximum loss is -$147.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ELAN long put?
The breakeven for the ELAN long put priced on this page is roughly $18.53 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ELAN market-implied 1-standard-deviation expected move is approximately 13.73%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on ELAN?
Long puts on ELAN hedge an existing long ELAN stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying ELAN exposure being hedged.
How does current ELAN implied volatility affect this long put?
ELAN ATM IV is at 47.90% with IV rank near 35.84%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related ELAN analysis